JCJoanne Sarah Carpenter

Joanne Sarah Carpenter

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joanne Sarah Carpenter has a total of 229 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Seasonal Variation in Mood and Associated Patterns of Sleep, Activity, Circadian Rhythms and Light

    by Mirim Shin, Emiliana Tonini, Joanne S Carpenter, Mathew Varidel, Alissa Nichles, Natalia Zmicerevska, Elizabeth Phung, Connie Janiszewski, Minji Park, Daniel Froggatt, et al.

    The mechanisms underlying seasonal mood variation are incompletely characterised. We tested whether wearable-measured sleep, activity, circadian and light exposure patterns are associated with seasonal mood variation in young Australians with emerging mood disorders. We analysed 733 observation periods from 422 participants (mean age 24.3 ± 5.5 years; 63% female) attending early-intervention clinics. Each observation included a clinical assessment paired with ≥5 valid days of wrist actigraphy. Season was modelled using sine-cosine functions of day-of-year. Sleep, activity and circadian features were reduced using joint and individual variation explained (JIVE). Light exposure features were reduced using principal component analysis (PCA) applied to light regularity, timing and exposure interval across 7 illuminance thresholds. Linear mixed-effects models tested seasonal effects on clinical outcomes; indirect associations for 12 candidate JIVE/PCA variables were estimated by cluster bootstrap. Depressive symptoms (β = −0.67, P = .023) and negative symptoms (β = −0.17, P = .041) peaked in winter, whereas manic symptoms peaked in autumn (β = 0.24, P = .019). Winter increases in negative symptoms were associated with an ‘extended sleep with phase-delayed activity’ profile (indirect β = −0.015, P < .002) and a ‘constrained pattern of moderate-to-bright indoor light exposure’ profile (indirect β = −0.038, P = .002), reflecting high day-to-day consistency with a narrow daily exposure window. The light association persisted after adjustment for time spent above the light threshold, which itself was not associated with symptoms. Winter increases in depressive symptoms were associated with lower overall physical activity levels (indirect β = −0.009, P = .040). No indirect associations were identified for manic symptoms. In this transdiagnostic youth sample, seasonal variation in mood was modest but was accompanied by differences in how personal light exposure was arranged across the day, not only in how much light was received and in daily activity patterns. These cross-sectional associations identify light patterning and activity rhythms as candidate modifiable targets for prospective and interventional research.

  • Open Access

    Longer Sleep Duration Predicts Progression to Bipolar or Psychotic Disorders in Youth Accessing Early Intervention Mental Health Services

    by Joanne S. Carpenter, Jacob J. Crouse, Mathew Varidel, Emiliana Tonini, Mirim Shin, Natalia Zmicerevska, Alissa Nichles, Daniel F. Hermens, Kathleen R. Merikangas, Elizabeth M. Scott, et al.

    Background: While growing evidence implicates sleep‐wake and circadian rhythm disturbances (SCRDs) in the onset and course of mood and psychotic disorders, longitudinal studies using objective measures are limited. This clinical cohort study examined whether actigraphy‐derived SCRDs (sleep duration, timing, and efficiency) predicted transition to (i) any full‐threshold mental disorders; and then specifically; (ii) full‐threshold bipolar or psychotic disorders; or (iii) other full‐threshold (i.e., depressive or anxiety) disorders, in youth accessing mental health care. Methods: Actigraphy monitoring was completed for 5–23 days in 250 participants (aged 12–30) presenting to youth‐focused early intervention services in Sydney, Australia. Participants were followed longitudinally as part of the Optymise cohort for at least 6+ months (up to 8 years; median 2.5 years). Logistic regression and Cox proportional hazards models estimated associations between SCRDs and illness progression, after controlling for relevant baseline clinical and demographic covariates (e.g., age, sex, social and occupational functioning, mania‐like and psychotic‐like experiences, medication use). Results: Longer sleep duration at baseline predicted higher odds of transition (OR = 2.23 [95% CI = 1.38–3.74]), and shorter time‐to‐transition (HR = 2.05 [95% CI = 1.23–3.40]) to full‐threshold bipolar or psychotic disorders. This effect remained significant after controlling for clinical covariates. Later sleep midpoint predicted transition to any full‐threshold mental disorder (OR = 1.46 [95% CI = 1.02–2.17]) at the uncorrected significance level. Conclusions: Excessive sleep duration may represent an early marker of vulnerability for progression to severe mental illness. Findings support the prognostic utility of objective measures of SCRDs to guide indicated prevention and early intervention.

  • Open Access

    Cumulative Indicators of Circadian Rhythm Disturbance and its Clinical, Functional and Genetic Correlates in the Brisbane Longitudinal Twin Study

    by Mirim Shin, Emiliana Tonini, Joanne S Carpenter, Brittany L Mitchell, Baptiste Couvy-Duchesne, Shin H Park, Richard Parker, Enda M Byrne, Samuel Hockey, Anna Treneman, et al.

    Background: Circadian rhythm disturbances (CRDs) are transdiagnostic risk factors across mental disorders. We examined CRD-associated phenotypes, their heritability, and clinical, functional and genetic correlates, cross-sectionally, in young adults from the Brisbane Longitudinal Twin Study. Methods: We assessed 2,773 community-based participants (25.6±4.1 years; 57.8% female). Six CRD-associated phenotypes (seasonality, hypersomnia, social jetlag, delayed sleep, evening preference, sleep inertia) were included. Associations of CRD-load (number of CRDs) with clinical and functional outcomes, and with polygenic risk scores (PRS) for mental health, physical health, and sleep/circadian traits, were tested using linear, negative binomial, or logistic regression, with family-clustered standard errors. Heritability of CRD-phenotypes was estimated using structural equation modelling. Results: Almost half the sample (49.2%) reported experiencing ≥1 CRD-phenotype and 20.5% reported ≥2. Four CRD-phenotypes (hypersomnia, social jetlag, delayed sleep, evening preference) were significantly heritable (h2=0.19-0.48). Higher CRD-load was associated with greater psychological distress (β=0.96, p<0.001), more psychological symptoms (incidence rate ratio [IRR]=1.07-1.40), higher odds of a full-threshold mental disorder (OR=1.28, p<0.001), and greater functional impairment (days-in-bed, IRR=1.55; days-out-of-role, IRR=1.43). In genotyped participants (n=2,301), CRD-load was associated with mood-disorder PRS (major depression [OR=1.14, p=0.003] and bipolar disorder [OR=1.14, p=0.002]) but not PRSs for schizophrenia, attention deficit hyperactivity disorder, autism, neuroticism or anxiety. Trends towards increased PRSs for metabolic traits did not survive Bonferroni-correction. Conclusions: CRD-load was associated with clinical symptoms, functional impairment, and mood-related genetic liability. These findings support further evaluation of brief assessments of circadian-associated phenotypes for identifying young people at greater clinical burden and informing circadian-focused prevention and early intervention strategies.

  • Open Access

    MELODY trial: study protocol for a 12-week randomised controlled trial of adjunctive melatonin, digital cognitive behavioural therapy for insomnia or pill placebo to improve depressive symptoms in young adults with mood disorders

    by Jacob J Crouse, Mirim Shin, Samuel J Hockey, Elie Jeon, Nathan Bradshaw, Alissa Nichles, Natalia Zmicerevska, Min Kyung Chong, Hannah You, Naomi R Wray, et al.

    Objectives: Sleep and circadian rhythm disturbances are proposed to be pathophysiological mechanisms underlying some cases of depressive and bipolar (mood) disorders. An unresolved clinical question is whether sleep and circadian-based therapies are effective antidepressants for young adults (18–30 years) with a mood disorder. Method and analysis: MELODY (Melatonin for Depression in Youth) is an investigator-initiated, single-centre, phase 3, randomised controlled trial with two blinded pharmacological arms (melatonin vs placebo) and one open-label digital intervention arm (digital cognitive behavioural therapy for insomnia (dCBT-I)). The trial is testing whether 12 weeks of adjunctive melatonin or dCBT-I are more effective than pill placebo at reducing depressive symptoms in 660 young people aged 18–30 years with a Structured Clinical Interview for (Diagnostic and Statistical Manual of Mental Disorders, fifth edition; SCID-5) diagnosis of Major Depressive Disorder or Bipolar Disorder type II, moderate to severe depressive symptoms and significant sleep or sleep-wake complaints. The week 12 primary outcome is depressive symptoms (Quick Inventory of Depressive Symptomatology, Adolescent version). Secondary outcomes include partial remission of the Major Depressive Episode (SCID-5) and change in other mental health symptoms, sleep, functioning or quality of life. A subset of participants will undergo in-home assessment of sleep physiology (Sleep Profiler) and in-lab assessment of circadian rhythms (dim-light melatonin onset) to examine biological changes. A 6-month follow-up will explore durability of treatment effects. Mediation analyses will test whether sleep or circadian rhythm changes play a causal role in antidepressant effects. Ethics and dissemination: MELODY has been reviewed and approved by the Human Research Ethics Committee (HREC) of the Sydney Local Health District (HREC Approval Number: X23-0450, Protocol version: 1.4, 7/7/25). The findings of the MELODY trial will be disseminated into the scientific and clinical communities via refereed publications, talks and other professional and media outlets. The Brain and Mind Centre’s Lived Experience Working Group will contribute to dissemination of MELODY’s findings via youth-friendly methods (eg, social media videos, explainers). Trial registration number: ACTRN12624000017527.

  • Open Access

    Consecutive day effects between sleep quality and affective symptoms among youth in the Brazilian High-Risk Cohort study

    by Mathew R Varidel, Luke Borgnolo, Victor An, Joanne S Carpenter, Ian B Hickie, Pedro M Pan, Francisco da Silva, Jacob J Crouse, Euripedes C Miguel, Luis A Rohde, et al.

    Background: Bidirectional next-day associations between sleep disturbances and affective symptoms have been shown in previous research, yet the consecutive day effects between these factors remains poorly understood. Methods: We analysed longitudinal ecological momentary assessment (EMA) data obtained from a subsample of young persons in the Brazilian High-Risk Cohort (BHRC) study collected in 2020-2021. Participants reported sleep quality each morning and rated affective symptoms relating to mood, anxiety, and energy four times daily for 28 days. We selected 88 individuals (17.83±1.74 years, 56 [63.6%] female gender) with at least one instance where individuals were observed three-days in a row. Within-person bidirectional next-day effects between sleep quality and affective symptoms were estimated using mixed-effects regression analysis adjusting. We then applied g-estimation approaches to estimate the effect that lagged sleep quality and consecutive improvements in sleep quality had on affective symptoms. Results: Sleep quality and affective symptoms had bidirectional next-day effects, with sleep quality tending to have greater influence on affective symptoms than the reverse. Improved lagged sleep quality had positive effects on affective symptoms incrementally above the prior night's sleep quality. Also, improvement of sleep quality across consecutive days had incremental and approximately equal effects on affective symptoms. Conclusions: Sleep quality and affective symptoms exhibit a feedback loop, whereby poor sleep quality influences affective symptoms over consecutive days. Breaking these feedback loops, by improving sleep quality across several consecutive nights should improve affective symptoms. This supports interventions that target sustained improvement in sleep and possibly circadian regulation to improve affective symptoms.

  • Open Access

    Essential Information About Chronobiology and Chronotherapy for the Optimal Care of People With Bipolar Disorders: An Expert Consensus

    by Jacob J. Crouse, Victoria Loblay, Anthony Jorm, Timothy R. Wong, Zsofi de Haan, Carla Gorban, Mirim Shin, Emiliana Tonini, Chris Aiken, Lauren B. Alloy, et al.

    Introduction: Circadian dysfunction is involved in the pathophysiology of bipolar disorders (BD), and circadian‐based interventions are gaining recognition in their management. Moreover, basic and epidemiologic research has generated findings inspiring circadian‐informed self‐ and clinician‐management strategies. Despite these gains, many Clinical Practice Guidelines and clinical training programs have not incorporated this evidence in their recommendations and curricula. This International Society for Bipolar Disorders (ISBD) Chronobiology and Chronotherapy Task Force position paper reports a Delphi‐based expert consensus on what is essential for mental health clinicians to know about the chronobiology and chronotherapy of BD. Methods: An initial pool of statements was extracted from academic and grey literature, and experts could suggest additional statements. Statements were rated on a 5‐point scale (‘essential’; ‘important’; ‘don't know/depends’; ‘unimportant’; ‘should not be included’). Consensus was reached when statements were rated as essential or important by ≥ 80% of experts. Results: Thirty experts from 15 countries in Europe, North and South America, and the Asia Pacific participated (mean age of 55.3 years [SD = 11.8]; 40% female; 83% psychiatrists; mean clinical experience of 26 years [SD = 10.8]). Eight‐hundred‐and‐thirty‐seven statements were rated across three rounds. Consensus was reached on 342 statements spanning four major themes: basic circadian science; circadian health and disruption; chronobiology of BD; and six chronotherapies (e.g., protocols, outcomes, risks/contraindications). Conclusions: An expert consensus was obtained on the essential information about the chronobiology and chronotherapy of BD, intended to help clinicians optimise their management of BD. Dissemination of this knowledge is expected to enhance the training and efficacy of clinicians.


  • Proposal for Circadian Rhythms and Their Behavioral Outputs as Biomarkers in DSM-6 : Response to Cuthbert et al.

    by Jacob J. Crouse, Joanne S. Carpenter, Angus C. Burns, Tone E. G. Henriksen, Michael J. McCarthy, Kathleen R. Merikangas, Nicholas Meyer, Jan Scott, Mirim Shin, Daniel J. Smith, et al.


  • Open Access

    Sleep-Wake and Circadian Targeted Interventions for the Early Course of Bipolar Disorder: New Evidence, Gaps and Directions

    by Zsofi de Haan, Min K. Chong, Joanne S. Carpenter, Emiliana Tonini, Mirim Shin, Ian B. Hickie, Jacob J. Crouse

    Purpose of Review: There is accumulating evidence that sleep-wake and circadian targeted interventions (chronotherapeutics) are effective in the management of bipolar disorders (BD). However, little is known about chronotherapeutics in the early course of BD. This targeted narrative review aims to provide an update of what we have learned from trials in this area in the past three years. Recent Findings: Some progress has been made in the investigation of the effects of a small number of chronotherapeutics (e.g., lithium, Interpersonal and Social Rhythm Therapy) on mood, sleep, sleep-wake cycles, or circadian rest-activity rhythms in the early course of BD. One particularly noteworthy finding from a randomised controlled trial is that lithium influences the timing of rest-activity rhythms in individuals early in the course of BD, and that changes in rest-activity rhythms might precede changes in mood states. We did not identify new studies on bright light therapy, dark therapy, or melatonergic or orexinergic agents that were relevant to the early course of BD (as most studies were in middle-aged or older adults with long-standing course of illness). Summary: Despite the promise of chronotherapeutics in the management toolkit for BD, there is a dearth of recent clinical trial evidence focused on recent-onset, youth, and early course samples. We encourage researchers working on chronotherapeutics in BD to focus efforts on the early course of BD (or at minimum conduct sub-analyses in recent-onset cases) and to examine objective measures of sleep-wake and circadian rhythms (e.g., actigraphy) as mediators or moderators of clinical effects (both symptom and functional improvements).


  • Open Access

    Seasonal variation in mood and the dynamics of sleep, activity, circadian rhythms, and light

    by Mirim Shin, Emiliana Tonini, Joanne S Carpenter, Mathew Varidel, Alissa Nichles, Natalia Zmicerevska, Elizabeth Phung, Connie Janiszewski, Minji Park, Daniel Froggatt, et al.

    Background: Mood symptoms vary seasonally, yet the underlying mechanisms remain unclear. We tested whether wearable-derived sleep, activity, circadian, and light exposure patterns mediate seasonal effects on mood in youth with emerging mood disorders. Methods: We analysed 733 observation periods from 422 Australian youth (mean age 24.3±5.5 years; 63% female) attending early-intervention mental health services. Each observation comprised a clinical assessment paired with ≥5 valid days of GENEActiv wrist actigraphy. Season was modelled using sine-cosine functions of day-of-year. Sleep, activity, and circadian features were reduced using Joint and Individual Variation Explained, and light exposure features were reduced via principal components analysis. Linear mixed-effects models tested seasonal effects on depressive, psychiatric, manic, and functional outcomes. Mediation was examined using Sobel screening followed by cluster bootstrapping (1,000 iterations). Results: Depressive (β=−0.67, p=0.023) and negative symptoms (β=−0.17, p=0.041) peaked in winter, whereas manic symptoms peaked in autumn (β=0.24, p=0.018). Reduced day-to-day variability in moderate-to-bright ambient light exposure (fewer transitions to brighter environments) mediated winter increases in depressive (indirect β=−0.06, p=0.006) and negative symptoms (indirect β=−0.05, p<0.001). Higher activity levels partially mediated season’s effect on depressive symptoms (indirect β=−0.010, p=0.032). Extended sleep with nocturnal activity mediated season’s effect on negative symptoms (indirect β=−0.02, p=0.001). No mediators emerged for manic symptoms. Conclusions: Light exposure variability—reflecting constrained engagement with brighter environments during winter—emerged as the dominant mediator of seasonal mood worsening in Australian youth, with smaller contributions from sleep-activity-circadian patterns. These findings identify daily light variability as a promising, modifiable target for intervention.

  • Open Access

    The effect of sleep–wake behaviors on the onset of mania in youth: A computational model

    by Kirill Glavatskiy, Ian B. Hickie, Jacob J. Crouse, William Capon, Ante Prodan, Jan Scott, Kathleen Merikangas, Joanne S. Carpenter, Mathew Varidel, Elizabeth M. Scott, et al.

    Background: Bipolar disorder is a recurrent and disabling condition, with a critical clinical need to prevent transitions from euthymia or depression (normal or low activation states) to mania (a high activation state). This study investigates how disruptions in sleep–wake and circadian rhythms may trigger these high activation states, to inform more effective relapse prevention strategies. Methods: We developed a computational agent-based model integrating empirical evidence, clinical expertise, and lived experience to simulate how 24-hour sleep–wake behaviors (SWBs) influence manic episodes. Individual characteristics were drawn from the Brain and Mind Youth Cohort ( N = 2,330), and multiple scenarios were simulated to assess how SWB dynamics affect the emergence and course of mania. Results: In the absence of all irregularities, no individuals experienced a manic episode. Removing behavioral feedback loops resulted in a substantial reduction in manic episodes and delayed onset. In contrast, eliminating light–dark entrainment slightly increased the frequency of manic episodes, suggesting that seasonal adaptation plays a stabilizing role. When examining components of SWB separately, removing sleep irregularities alone had only a modest effect on mania rates, whereas reducing activity irregularities led to the largest benefit: a significant drop in mean manic episodes, a delay in onset, and preventing mania in 65% of the simulated agent population. Conclusions: Our findings highlight the value of computational modeling for uncovering causal dynamics in mental health. These specific findings demonstrate how daily irregularities in sleep–wake behavior may be a necessary condition for mania. Targeting behavioral regularity may offer a powerful pathway for prevention and early intervention.